h-bulluck

Biography

Name:

Heeraj Bulluck

Title:

Dr

Institution:

Norfolk and Norwich University Hospital

Email:

[email protected]

Website:

https://scholar.google.com/citations?user=Meu9JEUAAAAJ&hl=en

Early career investigator (ECI):

No

Short biography of member:

I am originally from Mauritius and completed my medical degree in Beijing, China in Mandarin language. I am currently settled in the UK. I completed my PhD at UCL and I am in the final 1 year of my subspecialty training in interventional cardiology. I grew passionate about research over the past few years and my ambition is to pursue a career in both academia and clinical work in the future in the field of cardioprotection and ischemia-reperfusion injury in STEMI

Country:

GB, United Kingdom of Great Britain and Northern Ireland

Publications list:

Bulluck H. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. (letter to the editor) N Engl J Med. 2018 Jan 18;378(3):298.

Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Nordin S, Sirker A, Herrey AS, Manisty C, Moon JC, Hausenloy DJ. Redefining viability by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction. Sci Rep. 2017 Nov 7;7(1):14676.

Bulluck H, Maiti R, Chakraborty B, Candilio L, Clayton T, Evans R, Jenkins DP, Kolvekar S, Kunst G, Laing C, Nicholas J, Pepper J, Yellon DM, Hausenloy DJ. Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality. Heart. 2017 Aug 9. pii: heartjnl-2017-311760.

Bulluck H, Hammond-Haley M, Fontana M, Knight DS, Sirker A, Herrey AS, Manisty C, Kellman P, Moon JC, Hausenloy DJ. Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping. J Cardiovasc Magn Reson. 2017 Aug 1;19(1):57.

Bulluck H, Bryant JA, Lim MX, Tan XW, Ramlall M, Francis R, Kotecha T, Cabrera-Fuentes HA, Knight DS, Fontana M, Moon JC, Hausenloy DJ. Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping. Sci Rep. 2017 Jul 7;7(1):4871.

Bulluck H, Hausenloy DJ. Mapping Myocardial Salvage Index by Extracellular Volume Fraction: Are We There Yet? Circ Cardiovasc Imaging. 2017 Jul;10(7). pii: e006680.

Bulluck H, Bryant JA, Tan JZ, Go YY, Le TT, Tan RS, Lim TK, Tang HC, Lath N, Low AS, Chin CWL, Cook SA, Hausenloy DJ. Gender difference in native myocardial T1 in a healthy Chinese volunteer cohort. Cardiovascular Imaging Asia 2017 Apr;1(2):110-115.

Bulluck H, Nicholas J, Crimi G, White SK, Ludman AJ, Pica S, Raineri C, Cabrera-Fuentes HA, Yellon D, Rodriguez-Palomares J, Garcia-Dorado D, Hausenloy DJ. Reply to “circadian variation in acute myocardial infarction size: likely involvement of the melatonin and suprachiasmatic nuclei”. Int J Cardiol. 2017 May 15;235:192-193.

Bulluck H, Go YY, Crimi G, Ludman AJ, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Pica S, Raineri C, Sirker A, Herrey AS, Manisty C, Groves A, Moon JC, Hausenloy DJ. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017 Mar 13;19(1):26.

Bulluck H*, Zhou C, Fang N, Hausenloy DJ. Age and Surgical Complexity impact on Renoprotection by Remote Ischemic Preconditioning during Adult Cardiac Surgery: A Meta analysis. Scientific Rep. 2017 Mar 16;7(1):215. (joint first author)*

Bulluck H, Hammond-Haley M, Weinmann S, Hausenloy DJ. Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials. JACC Cardiovasc Imaging, 2017 March:10 (3)

Bulluck H, Foin N, Tan JW, Low AF, Sezer M, Hausenloy DJ. Invasive Assessment Of The Coronary Microcirculation In Reperfused STEMI Patients: Where Do We Stand? Circ Intervention, 2017;10:e004373.

Bulluck H, Foin N, Cabrera-Fuentes HA, Yeo KK, Wong AS, Fam JM, Wong PE, Tan JW, Low AF, Hausenloy DJ. Reply: Meta-Analysis of the Index of Microvascular Resistance in Acute STEMI Using Incomplete Data. JACC Cardiovasc Interv. 2017 Feb 27;10(4):422.

Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Gonzalez-Lopez E, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon D, Moon JC, Hausenloy DJ. Diagnostic performance of T1 and T2 mapping to detect intramyocardial hemorrhage in reperfused STEMI patients. J Magn Reson Imaging. 2017 Feb 15.

Bulluck H, Nicholas J, Crimi G, White SK, Ludman AJ, Pica S, Raineri C, Cabrera-Fuentes HA, Yellon D, Rodriguez-Palomares J, Garcia-Dorado D, Hausenloy DJ. Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients. Int J Cardiol. 2016 Dec 19. pii: S0167-5273(16)34502-8.

Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Weinmann S, Sirker A, Herrey AS, Manisty C, Moon JC, Hausenloy DJ. Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance. Open Heart. 2016 Dec 12;3(2):e000535.

Bulluck H, Foin N, Carbrera-Fuentes HA, Yeo KK, Wong AS, Fam JM, Wong PE, Tan JW, Low AF, Hausenloy DJ. Index of Microvascular Resistance and Microvascular Obstruction in patients with Acute Myocardial Infarction. JACC Cardiovasc Interv 2016;9(20):2172-8.

Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, Fontana M, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon DM, Kellman P, Moon JC, Hausenloy DJ. Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment–Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling. Circulation: Cardiovascular Imaging 2016;9(10):e004940.

Bulluck H, Rosmini S, Abdel-Gadir A, White S. K, Bhuva A. N, Treibel T.A, Fontana M, Gonzalez-Lopez E, Reant P, Ramlall M, Hamarneh A, Sirker A, Herrey A.S, Manisty C, Yellon D, Kellman P, Moon J. C, Hausenloy D.J. Automated ECV mapping provides insights into the pathophysiology of LV remodeling post reperfused STEMI. Journal of the American Heart Association 2016; J Am Heart Assoc. 2016 Jul 11;5(7). pii: e003555.

Bulluck H, White SK, Fröhlich GM, Casson SG, O'Meara C, Newton A, Nicholas J, Weale P, Wan SM, Sirker A, Moon JC, Yellon DM, Groves A, Menezes L, Hausenloy DJ. Quantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016 Mar;9(3):e003900.

Bulluck H, Yellon RL, Yellon DM. Promising strategies to minimize reperfusion injury in STEMI. Minerva Cardioangiol. 2016 Feb 9. [Epub ahead of print]

Bulluck H, Hausenloy DJ. Letter by Bulluck and Hausenloy Regarding Article,

Bulluck H, Yellon DM, Hausenloy DJ. Reducing myocardial infarct size: challenges and future opportunities. Heart. 2016 Mar 1;102(5):341-8.

Bulluck H, Hausenloy DJ. Microvascular Obstruction: The Bane of Myocardial Reperfusion. Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):919-20.

Bulluck H, Sirker A, Loke YK, Garcia-Dorado D, Hausenloy DJ. Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials. Int J Cardiol. 2016 Jan 1;202:228-37.

Bulluck H, Candilio L, Hausenloy DJ. Remote Ischemic Preconditioning: Would You Give Your Right Arm to Protect Your Kidneys? Am J Kidney Dis. 2016 Jan;67(1):16-9.

Bulluck H, White SK, Rosmini S, Bhuva A, Treibel TA, Fontana M, Abdel-Gadir A, Herrey A, Manisty C, Wan SM, Groves A, Menezes L, Moon JC, Hausenloy DJ. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. J Cardiovasc Magn Reson. 2015 Aug 12;17(1):73.

Bulluck H, Fröhlich GM, Mohdnazri S, Gamma RA, Davies JR, Clesham GJ, Sayer JW, Aggarwal RK, Tang KH, Kelly PA, Jagathesan R, Kabir A, Robinson NM, Sirker A, Mathur A, Blackman DJ, Ariti C, Krishnamurthy A, White SK, Meier P, Moon JC, Greenwood JP, Hausenloy DJ. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. Clin Cardiol. 2015 May;38(5):259-66.

Bulluck H, Hausenloy DJ. Ischaemic conditioning: are we there yet? Heart. 2015 Jul;101(13):1067-77. Epub 2015 Apr 17.

Bulluck H, Maestrini V, Rosmini S, Abdel-Gadir A, Treibel TA, Castelletti S, Bucciarelli-Ducci C, Manisty C, Moon JC. Myocardial T1 mapping. Circ J. 2015;79(3):487-94. Epub 2015 Feb 6.

Bulluck H, Kwok CS, Ryding AD, Loke YK. Safety of short-term dual antiplatelet therapy after drug-eluting stents: An updated meta-analysis with direct and adjusted indirect comparison of randomized control trials. Int J Cardiol. 2015 Feb 15;181:331-9. Epub 2014 Dec 13.